Literature DB >> 22236856

HIV-related bronchiectasis in children: an emerging spectre in high tuberculosis burden areas.

R Masekela1, R Anderson, T Moodley, O P Kitchin, S M Risenga, P J Becker, R J Green.   

Abstract

BACKGROUND: Human immunodeficiency virus (HIV) infected children have an eleven-fold risk of acute lower respiratory tract infection. This places HIV-infected children at risk of airway destruction and bronchiectasis.
OBJECTIVE: To study predisposing factors for the development of bronchiectasis in a developing world setting.
METHODS: Children with HIV-related bronchiectasis aged 6-14 years were enrolled. Data were collected on demographics, induced sputum for tuberculosis, respiratory viruses (respiratory syncytial virus), influenza A and B, parainfluenza 1-3, adenovirus and cytomegalovirus), bacteriology and cytokines. Spirometry was performed. Blood samples were obtained for HIV staging, immunoglobulins, immunoCAP®-specific immunoglobulin E (IgE) for common foods and aeroallergens and cytokines.
RESULTS: In all, 35 patients were enrolled in the study. Of 161 sputum samples, the predominant organisms cultured were Haemophilus influenzae and parainfluenzae (49%). The median forced expiratory volume in 1 second of all patients was 53%. Interleukin-8 was the predominant cytokine in sputum and serum. The median IgE level was 770 kU/l; however, this did not seem to be related to atopy; 36% were exposed to environmental tobacco smoke, with no correlation between exposure and CD4 count.
CONCLUSION: Children with HIV-related bronchiectasis are diagnosed after the age of 6 years and suffer significant morbidity. Immune stimulation mechanisms in these children are intact despite the level of immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22236856     DOI: 10.5588/ijtld.11.0244

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  15 in total

1.  Longitudinal Changes in Spirometry in South African Adolescents Perinatally Infected With Human Immunodeficiency Virus Who Are Receiving Antiretroviral Therapy.

Authors:  Leah N Githinji; Diane M Gray; Sipho Hlengwa; Takwanisa Machemedze; Heather J Zar
Journal:  Clin Infect Dis       Date:  2020-01-16       Impact factor: 9.079

Review 2.  Pneumococcal vaccine and patients with pulmonary diseases.

Authors:  Mehdi Mirsaeidi; Golnaz Ebrahimi; Mary Beth Allen; Stefano Aliberti
Journal:  Am J Med       Date:  2014-05-20       Impact factor: 4.965

3.  Lung Function in South African Adolescents Infected Perinatally with HIV and Treated Long-Term with Antiretroviral Therapy.

Authors:  Leah Nyawira Githinji; Diane M Gray; Sipho Hlengwa; Landon Myer; Heather J Zar
Journal:  Ann Am Thorac Soc       Date:  2017-05

Review 4.  Bronchiectasis and other chronic lung diseases in adolescents living with HIV.

Authors:  Engi F Attia; Robert F Miller; Rashida A Ferrand
Journal:  Curr Opin Infect Dis       Date:  2017-02       Impact factor: 4.915

Review 5.  The Lung Immune Response to Nontypeable Haemophilus influenzae (Lung Immunity to NTHi).

Authors:  Paul T King; Roleen Sharma
Journal:  J Immunol Res       Date:  2015-05-31       Impact factor: 4.818

Review 6.  Universal antiretroviral therapy for HIV-infected children: a review of the benefits and risks to consider during implementation.

Authors:  Linda Barlow-Mosha; Victor Musiime; Mary-Ann Davies; Andrew J Prendergast; Philippa Musoke; George Siberry; Martina Penazzato
Journal:  J Int AIDS Soc       Date:  2017-06-27       Impact factor: 5.396

7.  The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis.

Authors:  Hamdan Al-Jahdali; Abdullah Alshimemeri; Abdullah Mobeireek; Amr S Albanna; Nehad N Al Shirawi; Siraj Wali; Khaled Alkattan; Abdulrahman A Alrajhi; Khalid Mobaireek; Hassan S Alorainy; Mohamed S Al-Hajjaj; Anne B Chang; Stefano Aliberti
Journal:  Ann Thorac Med       Date:  2017 Jul-Sep       Impact factor: 2.219

Review 8.  The challenge of chronic lung disease in HIV-infected children and adolescents.

Authors:  Heinrich C Weber; Robert P Gie; Mark F Cotton
Journal:  J Int AIDS Soc       Date:  2013-06-18       Impact factor: 5.396

Review 9.  Noninfectious pulmonary complications of human immunodeficiency virus infection.

Authors:  Bashar Staitieh; David M Guidot
Journal:  Am J Med Sci       Date:  2014-12       Impact factor: 2.378

10.  Chronic lung disease in HIV-infected children established on antiretroviral therapy.

Authors:  Jamie Rylance; Grace Mchugh; John Metcalfe; Hilda Mujuru; Kusum Nathoo; Stephanie Wilmore; Sarah Rowland-Jones; Edith Majonga; Katharina Kranzer; Rashida A Ferrand
Journal:  AIDS       Date:  2016-11-28       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.